Effective Pharmacologic Management of Alzheimer’s Disease

“Mini-mental state”

1975 • 82,784 citations

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

1969 • 16,855 citations

J Neuropsychiatry Clin Neurosci

1992 • 3,756 citations

Measurement of Functional Activities in Older Adults in the Community

1982 • 2,650 citations

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

1997 • 2,394 citations

The cholinergic hypothesis of Alzheimer's disease: a review of progress

1999 • 2,013 citations

Memantine in Moderate-to-Severe Alzheimer's Disease

2003 • 1,889 citations

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

2005 • 1,779 citations

Practice parameter: Management of dementia (an evidence-based review) [RETIRED]

2001 • 1,742 citations

Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory

2000 • 1,613 citations

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

1998 • 1,575 citations

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

1997 • 1,357 citations

Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil

2004 • 1,350 citations

Memantine for dementia

2006 • 1,031 citations

Diagnosis and Treatment of Alzheimer Disease and Related Disorders

1997 • 925 citations

A 5-month, randomized, placebo-controlled trial of galantamine in AD

2000 • 911 citations

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease

2004 • 866 citations

Galantamine in AD

2000 • 864 citations

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

2001 • 723 citations

Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of Change

1997 • 620 citations

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

2000 • 609 citations

The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial<sup>1</sup>

1999 • 581 citations

Ginkgo biloba for cognitive impairment and dementia

2009 • 575 citations

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

2005 • 513 citations

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

2001 • 505 citations

Commentary: Another piece of the Alzheimer's jigsaw

1999 • 502 citations

To: A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease

2001 • 486 citations

A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease

1998 • 473 citations

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

1993 • 422 citations

Rofecoxib

2004 • 390 citations

A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment

2005 • 386 citations

A Randomized, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting

2001 • 362 citations

Open-Label, Multicenter, Phase 3 Extension Study of the Safety and Efficacy of Donepezil in Patients With Alzheimer Disease

2001 • 359 citations

A 52-Week Study of the Efficacy of Rivastigmine in Patients with Mild to Moderately Severe Alzheimer’s Disease

2000 • 324 citations

Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease

2003 • 314 citations

Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC)

1997 • 310 citations

Galantamine for Alzheimer's disease and mild cognitive impairment

2006 • 306 citations

Efficacy of donepezil in mild cognitive impairment

2004 • 291 citations

Widely Spread Butyrylcholinesterase Can Hydrolyze Acetylcholine in the Normal and Alzheimer Brain

2002 • 279 citations

Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease

2002 • 251 citations

Advances in the Treatment of Alzheimer’s Disease: Benefits of Dual Cholinesterase Inhibition

2002 • 246 citations

Estrogen-containing hormone therapy and Alzheimer’s disease risk: Understanding discrepant inferences from observational and experimental research

2005 • 213 citations

Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden

2003 • 207 citations

A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease

2006 • 187 citations

Guidelines for managing Alzheimer's disease: part I. Assessment.

2002 • 184 citations

Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly

2005 • 180 citations

Reduction of Behavioral Disturbances and Caregiver Distress by Galantamine in Patients With Alzheimer’s Disease

2004 • 177 citations

Vitamin B12 for cognition

2003 • 172 citations

A Randomized, Double-Blind, Placebo-Controlled Trial of Two Doses of Ginkgo Biloba Extract in Dementia of the Alzheimers Type

2005 • 171 citations

Vitamin C and Vitamin E for Alzheimer's Disease

2005 • 171 citations

The Cognitive Benefits of Galantamine Are Sustained for at Least 36 Months

2004 • 163 citations

Vitamin B6 for cognition

2003 • 158 citations

Ginkgo Biloba for cognitive impairment and dementia

2002 • 158 citations

Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease who Failed to Benefit from Treatment with Donepezil

2002 • 116 citations

Lecithin for dementia and cognitive impairment

2000 • 116 citations

An Economic Evaluation of Donepezil in Mild to Moderate Alzheimer’s Disease: Results of a 1-Year, Double-Blind, Randomized Trial

2002 • 112 citations

Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study

2005 • 94 citations

Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications

2000 • 91 citations

Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors

2003 • 91 citations

NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease.

2004 • 86 citations

Acetyl-l-carnitine for dementia

2003 • 84 citations

Galantamine for Alzheimer’s Disease and Mild Cognitive Impairment

2007 • 80 citations

Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease

2004 • 66 citations

NMDA Receptor Antagonists

1998 • 65 citations

Melatonin for cognitive impairment

2005 • 52 citations

Impact of donepezil treatment for Alzheimer's disease on caregiver time

2004 • 51 citations

Drug Interactions with Cholinesterase Inhibitors

2003 • 48 citations

Impact of Rivastigmine on Costs and on Time Spent in Caregiving for Families of Patients With Alzheimer's Disease

2003 • 40 citations

Treatments for Alzheimer Disease

2005 • 38 citations

Complementary and Alternative Medicines in the Treatment of Dementia

2003 • 35 citations

Long-Term Cholinesterase Inhibitor Therapy for Alzheimer's Disease

2003 • 25 citations

Association between hormone replacement therapy and dementia: is it time to forget?

2005 • 23 citations

Treatment of Alzheimer's disease: an evaluation of the cholinergic approach.

1999 • 22 citations

Deleted Work

1955 • 0 citations